1887

Journal of General Virology header logo

Volume 80, Issue 4

Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex. Free

Abstract

The hepatitis C virus (HCV) genome encodes two membrane-associated envelope glycoproteins (E1 and E2), which are released from the viral polyprotein precursor by host signal peptidase cleavages. These glycoproteins interact to form a noncovalent heterodimeric complex, which is retained in the endoplasmic reticulum. HCV glycoproteins, E1 and E2, are heavily modified by N-linked glycosylation. A recent study has revealed that upon partial deglycosylation with endoglycosidase H only four of the five potential glycosylation sites of HCV glycoprotein E1 are utilized. In this work, the unused glycosylation site on the E1 glycoprotein was identified and the influence of N-linked glycosylation on the formation of the HCV glycoprotein complex was studied by expressing a panel of E1 glycosylation mutants in HepG2 cells. Each of the five potential N-linked glycosylation sites, located at amino acid positions 196, 209, 234, 305 and 325, respectively, on the HCV polyprotein, was mutated separately as well as in combination with the other sites. Expression of the mutated E1 proteins in HepG2 cells indicated that the fifth glycosylation site is not used for the addition of N-linked oligosaccharides and the Pro immediately following the sequon (Asn-Trp-Ser) precludes core glycosylation. The effect of each mutation on the formation of noncovalent E1E2 complexes was also analysed. As determined with the use of a conformation-sensitive monoclonal antibody, mutations at positions N2 and N3 had no, or only minor, effects on the assembly of the E1E2 complex, whereas a mutation at position N1 and predominantly at position N4 dramatically reduced the efficiency of the formation of noncovalent E1E2 complexes.

  • Received:
  • Accepted:
  • Published Online:
© Journal of General Virology 1999
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-4-887
1999-04-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/4/0800887a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-4-887&mimeType=html&fmt=ahah

References

  1. Alter M. J., Hadler S. C., Judson F. N., Mares A., Alexander W. J., Hu P. Y., Miller J. K., Moyer L. A., Fields H. A., Bradley D. W. 1990; Risk factors for acute non-A non-B hepatitis in the United States and association with hepatitis C virus infection. Journal of the American Medical Association 264:2231–2235
     [Google Scholar]
  2. Alter M. J., Margolis H. S., Krawczynski K., Judson F. N., Mares A., Alexander W. J., Hu P. Y., Miller J. K., Gerber M. A., Sampliner R. E., Meeks E. L., Beach M. J. 1992; The natural history of community-acquired hepatitis C in the United States. The sentinel counties chronic non-A, non-B hepatitis study team. New England Journal of Medicine 327:1899–1905
     [Google Scholar]
  3. Bartenschlager R., Ahlbornlaake L., Mous J., Jacobsen H. 1993; Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. Journal of Virology 67:3835–3844
     [Google Scholar]
  4. Bause E. 1983; Structural requirements of N-glycosylation ofproteins. Biochemical Journal 209:331–336
     [Google Scholar]
  5. Bergeron J. J., Brenner M. B., Thomas D. Y., Williams D. B. 1994; Calnexin: a membrane-bound chaperone of the endoplasmic reticulum. Trends in Biochemical Sciences 19:124–128
     [Google Scholar]
  6. Chamberlain J. P. 1979; Fluorographic detection of radioactivity in polyacrylamide gels with the water-soluble fluor, sodium salicylate. Analytical Biochemistry 98:132–135
     [Google Scholar]
  7. Choo Q.-L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. 1989; Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–362
     [Google Scholar]
  8. Choo Q.-L., Richman K. H., Han J. H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby A., Barr P. J., Weiner A. J., Bradley D. W., Kuo G., Houghton M. 1991; Genetic organisation and diversity of the hepatitis C virus. Proceedings of the National Academy of Sciences, USA 88:2451–2455
     [Google Scholar]
  9. Choukhi A., Ung S., Wychowski C., Dubuisson J. 1998; Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins. Journal of Virology 72:3851–3858
     [Google Scholar]
  10. Curling E. M., Hayter P. M., Baines A. J., Bull A. T., Gull K., Strange P. G., Jenkins N. 1990; Recombinant human interferon-gamma. Differences in glycosylation and proteolytic processing lead to heterogeneity in batch culture. Biochemical Journal 272:333–337
     [Google Scholar]
  11. Deleersnyder V., Pillez A., Wychowski C., Blight K., Xu J., Hahn Y. S., Rice C. M., Dubuisson J. 1997; Formation of native hepatitis C virus glycoprotein complexes. Journal of Virology 71:697–704
     [Google Scholar]
  12. De Martynoff G., Venneman A., Maertens G. 1997; Analysis of post-translational modifications of HCV structural proteins by using the vaccinia virus expression system. In Viral Hepatitis and Liver Disease Edited by Rizzetto M., Purcell R. H., Gerin H. Turin: Minerva Medica;
     [Google Scholar]
  13. Doms R. W., Lamb R. A., Rose J. R., Helenius A. 1993; Folding and assembly of viral membrane proteins. Virology 193:545–562
     [Google Scholar]
  14. Drillien R., Spehner D., Kirn A. 1982; Complementation and genetic linkage between vaccinia virus temperature-sensitive mutants. Virology 68:372–381
     [Google Scholar]
  15. Dubuisson J., Rice C. M. 1996; Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin. Journal of Virology 70:778–786
     [Google Scholar]
  16. Dubuisson J., Hsu H. H., Cheung R. C., Greenberg H. B., Russell D. G., Rice C. M. 1994; Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and sindbis viruses. Journal of Virology 68:6147–6160
     [Google Scholar]
  17. Fournillier-Jacob A., Cahour A., Escriou N., Girard M., Wychowski C. 1996; Processing of the E1 glycoprotein of hepatitis C virus expressed in mammalian cells. Journal of General Virology 77:1055–1064
     [Google Scholar]
  18. Gavel Y., von Heijne G. 1990; Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering. Protein Engineering 3:433–442
     [Google Scholar]
  19. Grakoui A., Mccourt D. W., Wychowski C., Feinstone S. M., Rice C. M. 1993a; Characterization of the hepatitis C virus-encoded serine proteinase – determination of proteinase-dependent polyprotein cleavage sites. Journal of Virology 67:2832–2843
     [Google Scholar]
  20. Grakoui A., Mccourt D. W., Wychowski C., Feinstone S. M., Rice C. M. 1993b; A second hepatitis-C virus-encoded proteinase. Proceedings of the National Academy of Sciences, USA 90:10583–10587
     [Google Scholar]
  21. Grakoui A., Wychowski C., Lin C., Feinstone S. M., Rice C. M. 1993c; Expression and identification of hepatitis C virus polyprotein cleavage products. Journal of Virology 67:1385–1395
     [Google Scholar]
  22. Hammond C., Braakman I., Helenius A. 1994; Role of N-linked oligosaccharides, glucose trimming and calnexin during glycoprotein folding in the endoplasmic reticulum. Proceedings of the National Academy of Sciences, USA 91:913–917
     [Google Scholar]
  23. Hebert D. N., Foellmer B., Helenius A. 1995; Glucose trimming and reglucosylation determine glycoprotein association with calnexin in the endoplasmic reticulum. Cell 81:425–433
     [Google Scholar]
  24. Helenius A. 1994; How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum. Molecular Biology of the Cell 5:253–265
     [Google Scholar]
  25. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K. 1991; Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proceedings of the National Academy of Sciences, USA 88:5547–5551
     [Google Scholar]
  26. Hijikata M., Mizushima H., Akagi T., Mori S., Kakiuchi N., Kato N., Tanaka T., Kimura K., Shimotohno K. 1993; Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. Journal of Virology 67:4665–4675
     [Google Scholar]
  27. Houghton M. 1996; Hepatitis C viruses. In Fields Virology 3rd edn pp 1035–1058 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott-Raven;
     [Google Scholar]
  28. Kieny M.-P., Lathe R., Drillien R., Spehner D., Skory S., Schmitt D., Wiktor T., Koprowski H., Lecocq J.-P. 1984; Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature 312:163–166
     [Google Scholar]
  29. Kohara M., Tsukiyama-Kohara K., Maki N., Asano K., Yamaguchi K., Miki K., Tanaka S., Hattori N., Matsuura Y., Saito I., Miyamura T., Nomoto A. 1992; Expression and characterization of glycoprotein gp35 of hepatitis C virus using recombinant vaccinia virus. Journal of General Virology 73:2313–2318
     [Google Scholar]
  30. Kornfeld R., Kornfeld S. 1985; Assembly of asparagine-linked oligosaccharides. Annual Review of Biochemistry 54:631–664
     [Google Scholar]
  31. Kuo G., Choo Q.-L., Alter H. J., Gitnick G. L., Redecker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stewens C. E., Tegtmeier G. E., Bonino F., Colombo M., Lee W. S., Kuo C., Berger K., Shuster J. R., Overby L. R., Bradley D. W., Houghton M. 1989; An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362–364
     [Google Scholar]
  32. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
     [Google Scholar]
  33. Lanford R. E., Notvall L., Chavez D., White R., Frenzel G., Simonsen C., Kim J. 1993; Analysis ofhepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells. Virology 197:225–235
     [Google Scholar]
  34. Lin C., Lindenbach B. D., Pragai B. M., Mccourt D. W., Rice C. M. 1994; Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. Journal of Virology 68:5063–5073
     [Google Scholar]
  35. Manabe S., Fuke I., Tanishita O., Kaji C., Gomi Y., Yoshida S., Mori C., Takamizawa A., Yosida I., Okayama H. 1994; Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3. Virology 198:636–644
     [Google Scholar]
  36. Marshall R. D. 1974; The nature and metabolism of the carbohydrate-peptide linkages of glycoproteins. Biochemical Society Symposia 40:17–26
     [Google Scholar]
  37. Matsuura Y., Miyamura T. 1993; The molecular biology ofhepatitis C virus. Seminars in Virology 4:297–304
     [Google Scholar]
  38. Matsuura Y., Harada S., Suzuki R., Watanabe Y., Inoue Y., Saito I., Miyamura T. 1992; Expression of processed envelope protein of hepatitis C virus in mammalian and insect cells. Journal of Virology 66:1425–1431
     [Google Scholar]
  39. Mellquist J. L., Kasturi L., Spitalnik S. L., Shakin-Eshleman S. H. 1998; The amino acid following an Asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency. Biochemistry 37:6833–6837
     [Google Scholar]
  40. Michalak J.-P., Wychowski C., Choukhi A., Meunier J.-C., Ung S., Rice C. M., Dubuisson J. 1997; Characterization of truncated forms of hepatitis C virus glycoproteins. Journal of General Virology 78:2299–2306
     [Google Scholar]
  41. Miller R. H., Purcell R. H. 1990; Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proceedings of the National Academy of Sciences, USA 87:2057–2061
     [Google Scholar]
  42. Mizushima H., Hijikata M., Asabe S. I., Hirota M., Kimura K., Shimotohno K. 1994; Two hepatitis C virus glycoprotein E2 products with different C termini. Journal of Virology 68:6215–6222
     [Google Scholar]
  43. Nakai K., Kanehisa M. 1988; Prediction of in vivo modification sites of proteins from their primary structures. Journal of Biochemistry 104:693–699
     [Google Scholar]
  44. Opdenakker G., Rudd P. M., Ponting C. P., Dwek R. A. 1993; Concepts and principles of glycobiology. FASEB Journal 7:1330–1337
     [Google Scholar]
  45. Pohl G., Kallstrom M., Bergsdorf N., Wallen P., Jornvall H. 1984; Tissue plasminogen activator: peptide analyses confirm an indirectly derived amino acid sequence, identify the active site serine residue, establish glycosylation sites, and localize variant differences. Biochemistry 23:3701–3707
     [Google Scholar]
  46. Purcell R. H. 1994; Hepatitis C virus: historical perspective and current concepts. FEMS Microbiology Review 14:181–191
     [Google Scholar]
  47. Rademacher T. G., Parekh R. B., Dwek R. A. 1988; Glycobiology. Annual Review of Biochemistry 57:786–830
     [Google Scholar]
  48. Ralston R., Thudium K., Berger K., Kuo C., Gervase B., Hall J., Selby M., Kuo G., Houghton M., Choo Q. L. 1993; Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. Journal of Virology 67:6753–6761
     [Google Scholar]
  49. Rice C. M. 1996; Flaviviridae: the viruses and their replication. In Fields Virology 3rd edn pp 931–959 Edited by Fields B. N. Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
     [Google Scholar]
  50. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Ohta Y., Choo Q. L., Houghton M., Kuo G. 1990; Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proceedings of the National Academy of Sciences, USA 87:6547–6549
     [Google Scholar]
  51. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual 2nd edn Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
     [Google Scholar]
  52. Santolini E., Migliaccio G., Lamonica N. 1994; Biosynthesis and biochemical properties of the hepatitis C virus core protein. Journal of Virology 68:3631–3641
     [Google Scholar]
  53. Shakin-Eshleman S. H., Remaley A. T., Eshleman J. R., Wunner W. H., Spitalnik S. L. 1992; N-linked glycosylation of rabies virus glycoprotein. Individual sequons differ in their glycosylation efficiencies and influence on cell surface expression. Journal of Biological Chemistry 267:10690–10698
     [Google Scholar]
  54. Shakin-Eshleman S. H., Spitalnik S. L., Kasturi L. 1996; The amino acid at the X position of an Asn-X-Ser sequon is an important determinant of N-linked core glycosylation efficiency. Journal of Biological Chemistry 271:6363–6366
     [Google Scholar]
  55. Simmonds P., Holmes E. C., Cha T.-A., Chan S.-W., McOmish F., Irvine B., Beall E., Yap P. L., Kolberg J., Urdea M. S. 1993; Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. Journal of General Virology 74:2391–2399
     [Google Scholar]
  56. Spaete R. R., Alexander D., Rugroden M. E., Choo Q. L., Berger K., Crawford K., Kuo C., Leng S., Lee C., Ralston R., Thudium K., Tung J. W., Kuo G., Houghton M. 1992; Characterization of the hepatitis E2/NS1 gene product expressed in mammalian cells. Virology 188:819–830
     [Google Scholar]
  57. Taylor J. W., Ott J., Eckstein F. 1985; The rapid generation of oligonucleotide-directed mutations at high frequency using phosphor-othioate-modified DNA. Nucleic Acids Research 13:8764–8785
     [Google Scholar]
  58. Tomei L., Failla C., Santolini E., Defrancesco R., Lamonica N. 1993; NS3 is a serine protease required for processing of hepatitis C virus polyprotein. Journal of Virology 67:4017–4026
     [Google Scholar]
  59. Ware F. E., Vassilakos A., Peterson P. A., Jackson M. R., Lehrman M. A., Williams D. B. 1995; The molecular chaperone calnexin binds Glc1Man9GlcNAc2 oligosaccharide as an initial step in recognizing unfolded glycoproteins. Journal of Biological Chemistry 270:4697–4704
     [Google Scholar]
  60. Zhang W. H., Liu C. B., Sun Y. D., Alter H. J., Shih J. W. 1990; Hepatitis C virus causing non-A, non-B hepatitis in plasmapheresis center. Lancet 335p353
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-4-887
Loading
Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex.
J. Gen. Virol. 80, 887 (1999); https://doi.org/10.1099/0022-1317-80-4-887
/content/journal/jgv/10.1099/0022-1317-80-4-887
/content/journal/jgv/10.1099/0022-1317-80-4-887
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error